Mometasone eluting resorbable scaffold (Lyra Therapeutics)
糠酸莫米松植入剂 (Lyra Therapeutics)
Report date: 2025/11/17 10:08:08
Base Information
Drug NameMometasone eluting resorbable scaffold (Lyra Therapeutics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[12]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaIND
Originator CompaniesLyra Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesLianBio Development (HK) LtdShanghai LianBio Development Co LtdLyra Therapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A